NanoString Unveils New DNA-RNA-Protein Chemistry as It Takes Aim at Immuno-Oncology Market | GenomeWeb

NEW YORK (GenomeWeb) – NanoString Technologies has taken a step toward addressing basic and clinical research needs in immunoncology with the launch of new chemistry that enables analysis of DNA, RNA, and protein analytes from the same sample, on the same cartridge, at the same time.

In addition to the launch, NanoString executives discussed the firm's plans to develop companion diagnostics with partners in the pharmaceutical industry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.